在华制药领域专利技术资源竞争--美国制药企业专利资源竞争比较及其启示

本文通过分析制药技术创新特征和创新资源竞争特征来分析多国制药企业在华技术资源竞争状态,研究认为,制药技术创新不同于其他制造业技术创新,制药技术创新活动具有非线性和非连续性,对基础性研究与开发活动高度依赖,因此适合于利用专利数据分析其创新资源的竞争状态,同时也对相应的国家创新体系提出挑战。文章提出使用技术领域的覆盖宽度和技术资源的集聚程度两个重要方面分析方法研究制药技术领域的专利数据。本文给出典型国家,特别是美国制药公司在华专利技术资源的发展特征,对比分析多国制药企业在我国的技术资源分布特征及其发展趋势,为我国相关产业政策和企业竞争战略制定提供参考。

Patent Technology Resource Competition between US Drug Companies' in China: An Empirical Comparison and Its Implications

This paper analyzes the competitive situation of technology resource in the multinational pharmaceutical companies by analyzing the nature of innovation activities and resources coompetion.It is considered that innovation in pharmaceutical fields is different from other manufactures for that the activities are rather non-liner and non-consistence in nature,highly dependent upon basic research and development,therefore,the innovation is more feasible to patent data based studies and also chanllages the corresponding national innovation system.The paper provides a statistical method with two important concepts of benchmark,named degree of technology scope and degree of technology convergence to study the patent data in pharmaceutical fields.It puts forward the development characters of patent technology resources in China of some typical country's pharmaceutical companies,especially of US company.It also contrastively analyzes the distribution characters and development tendency of technology resources in multinational pharmaceutical companies in China,and supplys references to the policy and competitive strategy for national relative industries.